Nature Medicine 12, 1056–1064 (2006); published online 3 September 2006; corrected after print 10 November 2006
In the version of this article initially published, the dose stated for zVAD-fmk administration was incorrect. The methods reported on page 1062 should read, “Twenty-four hours after intrapleural injection of carrageenan, mice were injected i.p. with 10 mg per kg of R-roscovitine and/or 5 mg per kg of zVAD-fmk (z-Val-Ala-DL-Asp-fluoromethylketone; Bachem).” Similarly, the legend to Figure 4, line 3, should read “C57/bl6 mice were treated with 10 mg per kg of R-roscovitine (i.p.) and/or 5 mg per kg of zVAD-fmk (i.p. at 4-h intervals).” The authors also made an error reporting the time of administration of K/Bxn serum in the legend to Figure 5, line 14. This should read “Mice (n =10 in each group) were injected twice (days 0 and 2) with K/BxN serum derived from arthritic (day 60) K/BxN transgenic mice.” The error has been corrected in the HTML and PDF versions of the article.
Additional information
The online version of the original article can be found at 10.1038/nm1468
Rights and permissions
About this article
Cite this article
Rossi, A., Sawatzky, D., Walker, A. et al. Correction: Corrigendum: Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med 12, 1434 (2006). https://doi.org/10.1038/nm1206-1434
Issue Date:
DOI: https://doi.org/10.1038/nm1206-1434
This article is cited by
-
Delayed neutrophil apoptosis may enhance NET formation in ARDS
Respiratory Research (2022)